Average Co-Inventor Count = 3.89
ph-index = 4
The patent ph-index is calculated by counting the number of publications for which an author has been cited by other authors at least that same number of times.
Company Filing History:
1. Boehringer Ingelheim International Gmbh (31 from 1,536 patents)
31 patents:
1. 12479827 - Heteroaromatic carboxamide derivatives as plasma kallikrein inhibitors
2. 12091399 - Phenyltetrazole derivatives as plasma kallikrein inhibitors
3. 11851418 - Heteroaromatic carboxamide derivatives as plasma kallikrein inhibitors
4. 11760745 - Heteroaromatic carboxamide derivatives as plasma kallikrein inhibitors
5. 10919859 - Benzylaminopyridylcyclopropanecarboxylic acids, pharmaceutical compositions and uses thereof
6. 10913720 - Benzyloxypyridylcyclopropanecarboxylic acids, pharmaceutical compositions and uses thereof
7. 10793530 - Benzylaminopyrazinylcyclopropanecarboxylic acids, pharmaceutical compositions and uses thereof
8. 10695334 - Heteroaromatic carboxamide derivatives as plasma kallikrein inhibitors
9. 10603317 - Benzylaminopyridylcyclopropanecarboxylic acids, pharmaceutical compositions and uses thereof
10. 10550127 - Indanylaminoazadihydrobenzofuranylacetic acids, pharmaceutical compositions for the treatment of diabetes
11. 10538490 - Benzylaminopyridylcyclopropanecarboxylic acids, pharmaceutical compositions and uses thereof
12. 10501440 - Heteroarylcarboxamide derivatives as plasma kallikrein inhibitors
13. 10253004 - Indanylaminopyrazinylcyclopropanecarboxylic acids, pharmaceutical compositions and uses thereof
14. 10125101 - Indanylaminopyridylcyclopropanecarboxylic acids, pharmaceutical compositions and uses thereof
15. 9617251 - Indanylaminopyridylcyclopropanecarboxylic acids, pharmaceutical compositions and uses thereof